The first patient has been dosed in a Phase 1 clinical trial that’s testing a gene therapy for people with…
Articles by Steve Bryson, PhD
Xspray Pharma has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval for its oral…
The U.S. Food and Drug Administration (FDA) will allow Hemispherian to test its first-in-class experimental therapy for glioblastoma in…
Sonnet Biotherapeutics is now testing its immunotherapy SON-1010, in combination with the immune checkpoint inhibitor Tecentriq (atezolizumab), in more…
A study found that analyzing levels of immune cells and related molecules in the bloodstream of people with glioma…
The U.S. Food and Drug Administration (FDA) has approved label updates for two Bristol Myers Squibb (BMS) CAR T-cell…
The U.S. Food and Drug Administration (FDA) has agreed to review an application for oral Inqovi (decitabine and cedazuridine) in…
Nearly all the people with relapsed or refractory multiple myeloma (RRMM) who took part in a Phase 2 clinical…
Exportin-1, a therapeutic target for nuclear export inhibitors — a class of drugs used to treat blood cancers…
Orca-T, Orca Bio‘s investigational allogeneic stem cell transplant for treating blood cell cancers, more than doubled the rate…